Consenting to HIV-positive organ donation in the USA: legal and ethical considerations in comparison with a South African context

References

• Human Immunodeficiency Virus Organ Policy Equity (HOPE) Act. Public Law 113-51; 113th Congress; November 21, 2013;127 STAT. 579.
   Google Scholar
• Muller E, Kahn D, Mendelson M. Renal transplantation between HIV-positive donors and recipients. N Engl J Med. 2010;362(24):2336–2337.
   PubMed Web of Science ®Google Scholar
• Muller E, Barday Z, Kahn D. HIV-positive-to-HIV-positive kidney transplantation. N Engl J Med. 2015;372(21):2070–2071.
   Google Scholar
• Horton R. Mbeki defiant about South African HIV/AIDS strategy. Lancet. 2000;356(9225):225.
   Web of Science ®Google Scholar
• Simelela NP, Venter WD. A brief history of South Africa’s response to AIDS. S Afr Med J. 2014;104(3 Suppl 1):249–251.
   Web of Science ®Google Scholar
• Abdool Karim SS, Churchyard GJ, Karim QA, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009;374(9693):921–933.
   PubMed Web of Science ®Google Scholar
• Connolly C, Shisana O, Colvin M, Stoker D. Epidemiology of HIV in South Africa – results of a national, community-based survey. S Afr Med J. 2004;94(9):776–781.
   PubMed Web of Science ®Google Scholar
• Shisana O, Hall EJ, Maluleke R, Chauveau J, Schwabe C. HIV/AIDS prevalence among South African health workers. S Afr Med J. 2004;94(10):846–850.
   PubMed Web of Science ®Google Scholar
• Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W. National HIV incidence measures – new insights into the South African epidemic. S Afr Med J. 2007;97(3):194–199.
   PubMed Web of Science ®Google Scholar
• Shisana O, Rehle T, Simbayi LC, et al. South African National HIV Prevalence, Incidence and Behaviour Survey, 2012. Cape Town: HSRC Press; 2014.
   Google Scholar
• Bor J, Fox MP, Rosen S, et al. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa. PLoS Med. 2017;14(11):e1002463.
   Web of Science ®Google Scholar
• Rehle TM, Hallett TB, Shisana O, et al. A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One. 2010;5(6):e11094.
   PubMed Web of Science ®Google Scholar
• Johnson LF, Mossong J, Dorrington RE, et al. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med. 2013;10(4):e1001418.
   PubMed Web of Science ®Google Scholar
• Boyarsky BJ, Hall EC, Singer AL, Montgomery RA, Gebo KA, Segev DL. Estimating the potential pool of HIV-infected deceased organ donors in the United States. Am J Transplant. 2011;11(6):1209–1217.
   PubMed Web of Science ®Google Scholar
• de Mulder M, York VA, Wiznia AA, et al. HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA. HIV Med. 2014;15(3):135–143.
   Web of Science ®Google Scholar
• Jacobs GB, Laten A, van Rensburg EJ, et al. Phylogenetic diversity and low level antiretroviral resistance mutations in HIV type 1 treatment-naive patients from Cape Town, South Africa. AIDS Res Hum Retroviruses. 2008;24(7):1009–1012.
   Web of Science ®Google Scholar
• Parboosing R, Naidoo A, Gordon M, Taylor M, Vella V. Resistance to antiretroviral drugs in newly diagnosed, young treatment-naive HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa. J Med Virol. 2011;83(9):1508–1513.
   Web of Science ®Google Scholar
• Nwobegahay JM, Bessong PO, Masebe TM, Mavhandu LG, Iweriebor BC, Selabe G. Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naive persons visiting a voluntary testing and counselling centre in northeastern South Africa. J Health Popul Nutr. 2011;29(4):303–309.
   Web of Science ®Google Scholar
• Nwobegahay J, Selabe G, Ndjeka NO, Manhaeve C, Bessong PO. Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naive patients entering antiretroviral treatment programs at two sites in northern South Africa. J Med Virol. 2012;84(12):1839–1843.
   Web of Science ®Google Scholar
• Pillay V, Ledwaba J, Hunt G, et al. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004. Antivir Ther. 2008;13(Suppl 2):101–107.
   Google Scholar
• Benatar SR, Mayosi BM. Health and health care in South Africa. N Engl J Med. 2015;372(1):96.
   Web of Science ®Google Scholar
• Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D. The health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009;374(9692):817–834.
   PubMed Web of Science ®Google Scholar
• Moosa MR, Meyers AM, Gottlich E, Naicker S. An effective approach to chronic kidney disease in South Africa. S Afr Med J. 2016;106(2):156–159.
   Web of Science ®Google Scholar
• Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010;363(21):2004–2014.
   PubMed Web of Science ®Google Scholar
• Kuo PC, Stock PG. Transplantation in the HIV+ patient. Am J Transplant. 2001;1(1):13–17.
   PubMed Web of Science ®Google Scholar
• Roland ME, Lo B, Braff J, Stock PG. Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients. Arch Intern Med. 2003;163(15):1773–1778.
   Google Scholar
• Boyarsky BJ, Segev DL. From bench to bill: how a transplant nuance became 1 of only 57 laws passed in 2013. Ann Surg. 2016;263(3):430–433.
   Web of Science ®Google Scholar
• Scherzer R, Heymsfield SB, Rimland D, et al; Study of Fat Redistribution, Metabolic Change in HIV Infection (FRAM). Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection. AIDS. 2017;31:71–79.
   Web of Science ®Google Scholar
• Taha H, Newby K, Das A, Das S. Attitude of patients with HIV infection towards organ transplant between HIV patients. A cross-sectional questionnaire survey. Int J STD AIDS. 2016;27(1):13–18.
   Web of Science ®Google Scholar
• Stock P, Roland M, Carlson L, et al. Solid organ transplantation in HIV-positive patients. Transplant Proc. 2001;33(7–8):3646–3648.
   Web of Science ®Google Scholar
• Roland M, Carlson L, Stock P. Solid organ transplantation in HIV-infected individuals. AIDS Clin Care. 2002;14(7):59–63.
   Google Scholar
• Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation. 2003;75(4):425–429.
   Web of Science ®Google Scholar
• Stock PG, Roland ME, Carlson L, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation. 2003;76(2):370–375.
   PubMed Web of Science ®Google Scholar
• Roland ME, Barin B, Carlson L, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant. 2008;8(2):355–365.
   PubMed Web of Science ®Google Scholar
• Dominguez-Gil B, Delmonico FL, Shaheen FA, et al. The critical pathway for deceased donation: reportable uniformity in the approach to deceased donation. Transpl Int. 2011;24(4):373–378.
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services. Human immunodeficiency virus (HIV) Organ Policy Equity (HOPE) Act safeguards and research criteria for transplantation of organs infected with HIV. Fed Register. 2015;80:34912–34921.
   Google Scholar
• Redd AD, Quinn TC, Tobian AA. Frequency and implications of HIV superinfection. Lancet Infect Dis. 2013;13(7):622–628.
   Web of Science ®Google Scholar
• Redd AD, Collinson-Streng A, Martens C, et al. Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing. J Clin Microbiol. 2011;49(8):2859–2867.
   Web of Science ®Google Scholar
• Redd AD, Mullis CE, Serwadda D, et al. The rates of HIV superinfection and primary HIV incidence in a general population in Rakai, Uganda. J Infect Dis. 2012;206(2):267–274.
   Web of Science ®Google Scholar
• Redd AD, Mullis CE, Wendel SK, et al. Limited HIV-1 superinfection in seroconverters from the CAPRISA 004 microbicide trial. J Clin Microbiol. 2014;52(3):844–848.
   Web of Science ®Google Scholar
• Canaud G, Dejucq-Rainsford N, Avettand-Fenoel V, et al. The kidney as a reservoir for HIV-1 after renal transplantation. J Am Soc Nephrol. 2014;25(2):407–419.
   PubMed Web of Science ®Google Scholar
• Waters L, Smit E. HIV-1 superinfection. Curr Opin Infect Dis. 2012;25(1):42–50.
   Web of Science ®Google Scholar
• Streeck H, Li B, Poon AF, et al. Immune-driven recombination and loss of control after HIV superinfection. J Exp Med. 2008;205(8):1789–1796.
   Web of Science ®Google Scholar
• Wearne N, Okpechi IG. HIV-associated renal disease – an overview. Clin Nephrol. 2016;86(13):41–47.
   Google Scholar
• Marras D, Bruggeman LA, Gao F, et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med. 2002;8(5):522–526.
   Web of Science ®Google Scholar
• Blumberg EA, Rogers CC; AST Infectious Diseases Community of Practice. Human immunodeficiency virus in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):169–178.
   Google Scholar
• Frassetto L, Thai T, Aggarwal AM, et al. Pharmacokinetic interactions between cyclosporine and protease inhibitors in HIV+ subjects. Drug Metab Pharmacokinet. 2003;18(2):114–120.
   PubMedGoogle Scholar
• Fogel J, editor. Undisclosed ARV drug use. HPTN Annual Meeting; 2013.
   Google Scholar
• Human Sciences Research Council Press. South African National HIV Prevalence, Incidence and Behaviour Survey, 2012. HSRC Press, South Africa, 2014. Available from: http://www.hsrc.ac.za/uploads/pageContent/4565/SABSSM%20IV%20LEO%20final.pdf. Accessed December 5, 2017.
   Google Scholar